CEO: Raul R. Rodriguez
Employees: 162
IPO: Nov 29, 2000
Prix
27,50 €
Variation
▲ 0,46 €
1,70%
Cap. Boursière
508,01M
Fourchette du Jour
27,35 €
28,23 €
Fourchette 52 Semaines
15,50 €
52,24 €
Volume
239 451
Moyenne 50J / 200J
31,80 €
32,98 €
Clôture Précédente
27,04 €
Quick Summary
Points Clés
Revenue grew 18,50% annually over 5 years — strong growth
Earnings grew 1999,08% over the past year
ROE of 185,94% indicates high profitability
Net margin of 124,72% shows strong profitability
Debt/Equity of 0,14 — conservative balance sheet
Generating 75,66M in free cash flow
Croissance
Revenue Growth (5Y)
18,50%
Au-dessus de la moyenne du secteur (9,60%)
Revenue (1Y)64,15%
Earnings (1Y)1999,08%
FCF Growth (3Y)N/A
Qualité
Return on Equity
185,94%
Au-dessus de la moyenne du secteur (3,61%)
ROIC21,16%
Net Margin124,72%
Op. Margin42,63%
Sécurité
Debt / Equity
0,14
En dessous de la moyenne du secteur (0,23)
Current Ratio2,42
Interest Coverage17,14
Valorisation
P/E Ratio
1,38
Au-dessus de la moyenne du secteur (0,23)
Forward P/EN/A
P/B Ratio1,30
EV/EBITDA4,15
Dividend Yield0,00%
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (638 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 1,4 | 0,2 |
| P/B | 1,3 | 2,9 |
| ROE % | 185,9 | 3,6 |
| Net Margin % | 124,7 | 3,9 |
| Rev Growth 5Y % | 18,5 | 9,6 |
| D/E | 0,1 | 0,2 |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 64,15% | Revenue Growth (3Y) | 58,67% |
| Earnings Growth (1Y) | 1999,08% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 18,50% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 294,28M | Net Income (TTM) | 367,02M |
| ROE | 185,94% | ROA | 71,46% |
| Gross Margin | 93,33% | Operating Margin | 42,63% |
| Net Margin | 124,72% | Free Cash Flow (TTM) | 75,66M |
| ROIC | 21,16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,14 | Current Ratio | 2,42 |
| Interest Coverage | 17,14 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 1,38 | Forward P/E | N/A |
| P/B Ratio | 1,30 | P/S Ratio | 1,73 |
| PEG Ratio | 0,00 | Forward PEG | N/A |
| EV/EBITDA | 4,15 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 14,89% | ||
| Market Cap | 508,01M | Enterprise Value | 520,73M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 294,28M | 179,28M | 116,88M | 120,24M | 149,24M |
| Net Income | 367,02M | 17,49M | -25,09M | -58,57M | -17,91M |
| EPS (Diluted) | 19,48 | 0,99 | -1,44 | -3,40 | -1,10 |
| Gross Profit | 274,66M | 160,63M | 109,77M | 118,49M | 148,15M |
| Operating Income | 125,47M | 24,19M | -20,49M | -55,55M | -12,50M |
| EBITDA | 127,88M | 28,51M | -16,98M | -53,87M | -11,29M |
| R&D Expenses | 33,30M | 23,38M | 24,52M | 60,27M | 65,24M |
| SG&A Expenses | 115,90M | 113,06M | 105,74M | 112,45M | 91,89M |
| D&A | 2,42M | 2,23M | 1,24M | 998 000,0 | 1,16M |
| Interest Expense | 7,32M | 7,92M | 6,87M | 3,71M | 4,86M |
| Income Tax | -245,20M | 881 000,0 | 0,0 | 0,0 | 605 000,0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 513,59M | 163,98M | 117,23M | 134,28M | 167,33M |
| Total Liabilities | 122,11M | 160,69M | 145,87M | 147,90M | 136,95M |
| Shareholders' Equity | 391,48M | 3,29M | -28,64M | -13,62M | 30,37M |
| Total Debt | 53,30M | 59,97M | 60,58M | 41,55M | 30,57M |
| Cash & Equivalents | 40,58M | 56,75M | 32,79M | 24,46M | 18,89M |
| Current Assets | 240,17M | 135,10M | 99,27M | 115,90M | 154,47M |
| Current Liabilities | 99,24M | 63,30M | 53,27M | 65,21M | 63,55M |
Scores de Stratégies
This stock passed the criteria for 5 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Light Compounder
#6 of 223
#14 of 153
#62 of 200
Custom
Full Throttle
#113 of 141
Custom
Lower Risk
#22 of 136
Activité Récente
Entré
Capital Light Compounder
Apr 2, 2026
Entré
Growth Investing (Philip Fisher)
Apr 2, 2026
Entré
Value Investing (Warren Buffett)
Apr 2, 2026
Entré
Full Throttle
Apr 2, 2026
Entré
Lower Risk
Apr 2, 2026